Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.
Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.
复制标题
DOI:
10.1016/j.ijpharm.2017.05.045
复制
发表时间:
2017-07-15
影响因子:
5.8
通讯作者:
Whittum-Hudson JA
中科院分区:
文献类型:
--
作者:
Ganda IS;Zhong Q;Hali M;Albuquerque RLC;Padilha FF;da Rocha SRP;Whittum-Hudson JA
Peptide-based vaccines have emerged in recent years as promising candidates in the prevention of infectious diseases. However, there are many challenges to maintaining in vivo peptide stability and enhancement of peptide immunogenicity to generate protective immunity which enhances clearance of infections. Here, a dendrimer-based carrier system is proposed for peptide-based vaccine delivery, and shows its anti-microbial feasibility in a mouse model of Chlamydia trachomatis. Chlamydiae are the most prevalent sexually transmitted bacteria worldwide, and also the causal agent of trachoma, the leading cause of preventable infectious blindness. In spite of the prevalence of this infectious agent and the many previous vaccine-related studies, there is no vaccine commercially available. The carrier system proposed consists of generation 4, hydroxyl-terminated, polyamidoamine (PAMAM) dendrimers (G4OH), to which a peptide mimic of a chlamydial glycolipid antigen—Peptide 4 (Pep4, AFPQFRSATLLL) was conjugated through an ester bond. The ester bond between G4OH and Pep4 is expected to break down mainly in the intracellular environment for antigen presentation. Pep4 conjugated to dendrimer induced Chlamydia-specific serum antibodies after subcutaneous immunizations. Further, this new vaccine formulation significantly protected immunized animals from vaginal challenge with infectious Chlamydia trachomatis, and it reduced infectious loads and tissue (genital tract) damage. Pep4 conjugated to G4OH or only mixed with peptide provided enhanced protection compared to Pep4 and adjuvant (i.e. alum), suggesting a potential adjuvant effect of the PAMAM dendrimer. Combined, these results demonstrate that hydroxyl-terminated PAMAM dendrimer is a promising polymeric nanocarrier platform for the delivery of peptide vaccines and this approach has potential to be expanded to other infectious intracellular bacteria and viruses of public health significance.
登录
查看更多内容
影响因子:
4.7
作者:
Gaertner, Hubert F.;Cerini, Fabrice;Hartley, Oliver
通讯作者:
Hartley, Oliver
影响因子:
--
作者:
Carter, J. D.;Espinoza, L. R.;Hudson, A. P.
通讯作者:
Hudson, A. P.
影响因子:
11.2
作者:
Daftarian, Pirouz;Kaifer, Angel E.;Serafini, Paolo
通讯作者:
Serafini, Paolo
影响因子:
4.9
作者:
Albertazzi, Lorenzo;Serresi, Michela;Beltram, Fabio
通讯作者:
Beltram, Fabio
影响因子:
3.9
作者:
Abu El-Asrar, AM;Geboes, K;Desmet, V
通讯作者:
Desmet, V